Sustained Effectiveness of Lanadelumab in Preventing Hereditary Angioedema Attacks: The ENABLE Study
Andrea Zanichelli(University of Milan), Inmaculada Martinez‐Saguer, Robin Lochbaum(Universität Ulm), Tamar Kinaciyan(Medical University of Vienna), Irmgard Andresen(Takeda (Switzerland)), Markus Magerl(Humboldt-Universität zu Berlin), Aharon Kessel(Technion – Israel Institute of Technology), Daniel N. Castaner(Takeda (United States)), Mona Al‐Ahmad(Kuwait University), Natalie Khutoryansky(Takeda (United States)), Maureen Watt(Takeda (United States)), Walter A. Wuillemin(Luzerner Kantonsspital), Emel Aygören‐Pürsün(Goethe University Frankfurt), Ramón Lleonart Bellfill(Bellvitge University Hospital), Mauro Cancian(University of Padua), Andreas Recke(University of Lübeck)
Cited by 0
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients
|Allergy|2004|301
Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
|Autoimmunity Reviews|2011|293
Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function
|The Journal of Immunology|2007|229